Prevalence of Intestinal Parasitic Infections in Relation to the HIV Status of Patients Attending the Care Units in Three Divisions in the Centre Region of Cameroon


avatar Stephanie Jupsa Mbiandou 1 , avatar Samuel Fosso 2 , 3 , avatar Edimo Bille 3 , avatar Armand Beleck Matoh 4 , avatar Hugues Nana Djeunga 1 , 5 , avatar Albert Same Ekobo 2 , 3 , avatar Flobert Njiokou 1 , *

1 Laboratory of Parasitology and Ecology, Faculty of Science, Department of Animal Biology and Physiology, University of Yaoundé I, Yaoundé, Cameroon

2 Department of Microbiology - Parasitology - Hematology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon

3 Laboratory of Parasitology, Yaoundé University Teaching Hospital, Yaoundé, Cameroon

4 National Committee for the Fight against AIDS, Bamenda, Cameroon

5 Center for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon

How to Cite: Jupsa Mbiandou S, Fosso S, Bille E, Beleck Matoh A, Nana Djeunga H, et al. Prevalence of Intestinal Parasitic Infections in Relation to the HIV Status of Patients Attending the Care Units in Three Divisions in the Centre Region of Cameroon. Int J Infect. 2019;6(2):e94337. doi: 10.5812/iji.94337.


International Journal of Infection: 6 (2); e94337
Published Online: July 21, 2019
Article Type: Research Article
Received: May 24, 2019
Revised: July 4, 2019
Accepted: July 10, 2019


Background: Depression of the immune system caused by the human immunodeficiency virus (HIV) promotes the onset of opportunistic infections including intestinal parasites.

Objectives: In this study, we are comparing the prevalence of these parasitic infections among individuals infected with HIV (HIV+) and non-infected (HIV-) enrolled in four HIV care units in the Centre Region of Cameroon.

Methods: A cross-sectional study was conducted and stool samples were collected from 283 HIV positive subjects and 245 seronegative subjects. These samples were processed using direct wet mount, formol-ether concentration, Kato-Katz procedure, modified Ziehl-Neelsen staining, and Baermann techniques to identify both common and opportunistic intestinal parasites. Logistic regression analyses were used to assess the association between HIV infection and socio-demographics factors as well as infection with intestinal parasites.

Results: A total of 123 (23.4%) individuals were found infected with at least one protozoan parasite species, and nine (1.7%) with intestinal worms. Overall, infection rates were 27.9% and 22.4% among HIV+ and HIV- subjects, respectively. The frequencies of Cryptosporidium spp. and Entamoeba histolytica/dispar were significantly more important among HIV+ subjects (P < 0.0455). Pentatrichomonas hominis and Entamoeba coli were significantly more prevalent among HIV- subjects (P < 0.0210). Heterogeneity was observed in the distribution of intestinal parasites, according to socio-demographic parameters. In addition, Cryptosporidium spp. was significantly associated with the decrease in CD4 cell count (P = 0.0035). The frequencies of infections with Cryptosporidium spp., Isospora belli, and Iodamoeba buetschlii were significantly more important in HIV positive patients not taking antiretroviral (P < 0.0226).

Conclusions: Cryptosporidium spp., Entamoeba histolytica/dispar, and Blastocystis spp. were the intestinal pathogens more often found among HIV infected individuals. HIV positive subjects were significantly more infected with intestinal parasites than seronegatives in intermediate and rural settings, among individuals aged more than 45 years and among unemployed individuals.

1. Background

Infection with human immunodeficiency virus (HIV) is an important public health concern worldwide (1, 2). Depression of the immune system caused by this virus promotes the onset of opportunistic infections that accelerate disease progression to AIDS (3, 4). Among these opportunistic infections, intestinal parasites are ranked among the main agents responsible for chronic and severe digestive disorders (5-7). Indeed, coccidiosis (cryptosporidiosis, isosporiasis, cyclosporiasis) and invasive strongyloidiasis have been the most frequently found intestinal parasitic diseases associated with the genesis of digestive dysfunctions (8-10). Though antiretroviral triple therapy (ART) dramatically improved the control of HIV, its accessibility in Sub-Saharan Africa remains challenging with sometimes shortage of the medication, as a consequence of economic difficulties (11-13). Unlike ART, the treatments of intestinal parasitic infections are largely affordable for many patients, and are sometimes provided free of charge (14-17). Given the government’s efforts in the provision of antiretrovirals in the different care units and the decrease in the cost of generic antiparasitic drugs, one would expect a reduction in the frequencies of opportunistic intestinal parasites.

2. Objectives

This study aimed at investigating the opportunistic character of intestinal parasites harbored by HIV infected patients in one of the most HIV affected regions in Cameroon.

3. Methods

3.1. Study Sites and Selection of Participants

The present study was conducted in the Centre Region of Cameroon where the prevalence of HIV (6.2%) is among the highest in the country (18). Three divisions (Mfoundi, Mbam & Kim, and Nyong & Mfoumou) with different levels of urbanization (urban, semi-rural/urban, and rural) were selected. The Mfoundi division is considered as an urban area, although some of its peripheral quarters are rural settings. Ntui and Akonolinga, respective capitals of Mbam & Kim and Nyong & Mfoumou divisions, are semi-urban/semi-rural cities (intermediate zones), though the constituting villages of these two divisions are rural (19). In addition to the urbanization criteria, these three divisions were also chosen because they have health facilities housing units for management of HIV patients.

Individuals eligible for this study were (i) both HIV positive (HIV+) and negative subjects (HIV-), (ii) aged one year and above, (iii) visiting the management unit (for HIV positive patients) or the counselling services for withdrawal of their HIV test results (for HIV negative individuals) of the targeted health facilities, and (iv) who had already spent at least one year in the study area. Only those who consented to participate in the study were enrolled. The recruitment of participants took place from July 2013 to September 2015, in the framework of a hospital-based cross-sectional study conducted in the Yaoundé University Teaching Hospital (CHUY), the Yaoundé Central Hospital (HCY), the Ntui District Hospital, and the Akonolinga District Hospital.

3.2. Socio-Demographic Data and Clinical Parameters

All relevant information regarding HIV status, socio-demographic factors, and clinical signs were collected through interview and consultation of medical notebooks of participants. The cluster of differentiation 4 (CD4) cell counts for three months’ follow-up were retrieved from the medical registers of HIV positive patients.

3.3. Sample Collection and Processing

A plastic vial was provided to each enrollee for stool sample collection. These vials were returned back with fresh stools for subsequent analyses.

Samples were processed using different complementary approaches (20-22). Directs wet mount of stool with normal saline (0.9% NaCl solution), and lugol’s iodine staining were used for the diagnosis of protozoa and helminths. The Kato-Katz procedure and Formalin-Ether (10%) concentration technique were also used for helminths eggs identification and cysts/oocysts detection, respectively. Finally, the modified Ziehl-Neelsen technique was used for the detection of coccidian oocysts, and the Baermann technique, a larval concentration technique, was also performed for the detection of Strongyloides larvae.

3.4. Statistical Analyses

All data relevant for this study were recorded into a purpose-built Microsoft Excel dataset and subsequently exported into PASW Statistics version 18 (SPSS Inc., Chicago, IL., USA) for statistical analysis. Prevalence were expressed as the percentage of infected individuals among the total number of individuals examined. The Pearson chi-square was used to compare prevalence between HIV infected and non-infected subjects, according to different covariates recorded in this study (socio-demographic characteristics and clinical status). Fisher exact probability test was used for small sample sizes. A binary logistic regression model was used to test the association between HIV status (response variable) and the different covariates listed above (explanatory variables). For all statistical analyses, the threshold for significance was set to 5%.

4. Results

4.1. Socio-Demographic and Clinical Parameters

A total of 528 individuals were recruited, including 283 (53.6%) HIV seropositive and 245 (46.4%) HIV seronegative subjects (Table 1). The higher percentage of participants was recorded in the Mfoundi (57.6%), and among non-agricultural workers or small businessmen (informal sector) (50.0%). Among the enrollees, 55.7% were originating from urban areas, 30.7% from semi-urban/rural areas, and 13.6% from rural settings. Furthermore, 32.6% males (82 HIV positive and 90 HIV negative) and 67.4% females (201 HIV positive and 155 HIV negative) were recorded. The sex ratio was female biased, both among HIV positive patients (2.45) and seronegative subjects (1.72). The mean age of HIV positive subjects was 43 years (standard deviation, SD: 10.5), ranging between 19 and 68 years old, while the mean age of HIV negative subjects was 30 years (SD: 17.4), ranging between 1 and 80 years. The clinical signs associated with digestive disorder presented during the last month (before sampling) by the participants were abdominal pain (78.0%), asthenia (52.8%), constipation (29.5%), anorexia (22.9%), flatulence (22.5%), nausea (15.1%), diarrhea (11.7%), and vomiting (5.3%). The frequencies of diarrhea, constipation, flatulence, and asthenia were significantly higher among HIV positive subjects (P < 0.0045).

Table 1. Distribution of Participants According to Divisions
DivisionsHIV Positives, No. (%)HIV Negatives, No. (%)
Mfoundi210 (74.2)94 (38.4)
Mbam & Kim22 (7.8)76 (31.0)
Nyong & Mfoumou51 (18.0)75 (30.6)
Total283 (53.6)245 (46.4)

4.2. Rate of Intestinal Parasitic Infections

A total of 123 (23.4%) participants were infected with protozoa and 9 (1.7%) with intestinal worms (Table 2). The global infection rates were 27.9% for HIV positive subjects and 22.4% for HIV negative individuals, the difference being not significant (P = 0.1502). Infection with HIV was positively associated with the presence of Cryptosporidium spp. (OR = 6.13; 95% CI: 1.80 - 20.90; P = 0.0010) and Entamoeba histolytica/dispar (OR = 2.21; 95% CI: 0.99 - 4.89; P = 0.0455). On the contrary, infection with HIV was negatively associated with the presence of Pentatrichomonas hominis (P = 0.0044) and Entamoeba coli (P = 0.0021).

Table 2. Rate of Intestinal Parasitic Infections in the Study Groups
Parasites Species HIV Positives, No. (%)HIV Negatives, No. (%)Total, No. (%)P Value
Protozoa72 (25.4)51 (20.8)123 (23.4)0.2102
Blastocystis spp.19 (6.7)27 (11.0)46 (8.7)0.0802
Entamoeba histolytica/dispar22 (7.8)9 (3.7)31 (5.9)0.0455a
Cryptosporidium spp.20 (7.1)3 (1.2)23 (4.4)0.0010a
Endolimax nana10 (3.5)9 (3.7)19 (3.6)0.9203
Pentatrichomonas hominis0 (0)7 (2.9)7 (1.3)0.0044a
Entamoeba coli0 (0)5 (2.0)5 (0.9)0.0210a
Iodamoeba buetschlii2 (0.7)2 (0.8)4 (0.8)1.0000
Entamoeba hartmanni2 (0.7)0 (0.0)2 (0.4)0.5016
Isospora belli2 (0.7)0 (0.0)2 (0.4)0.5016
Giardia intestinalis1 (0.4)0 (0.0)1 (0.2)1.0000
Ascaris lumbricoides6 (2.1)3 (1.2)9 (1.7)0.5143
Global infection rates79 (27.9)55 (22.4)134 (25.4)0.1502

aSignificant difference.

Ubiquitous parasites such as Blastocystis spp., Entamoeba histolytica/dispar, Cryptosporidium spp. and Endolimax nana were found in all settings. The frequency of Blastocystis spp. (10.9%) was higher in urban settings, while E. histolytica/dispar (10.5%), Cryptosporidium spp. (7.4%), E. coli (1.9%) and P. hominis (1.9%) displayed the greater frequencies in the semi-urban/rural areas. Endolimax nana (9.7%), Ascaris lumbricoides (8.3%), and Cryptosporidium spp. (8.3%) were more frequent in rural areas. Other species (Iodamoeba buetschlii, Entamoeba hartmanni, Isospora belli, Giardia intestinalis), tough displaying very low prevalence’s, were recorded in urban settings. Moreover, HIV negative individuals in urban zones were more infected with Blastocystis spp. (P = 0.0156). Cryptosporidium spp. (P = 0.0001) and E. histolytica/dispar (P = 0.0002) were found in high frequency among the HIV positive subjects in the semi-urban/rural zones. Regarding the variations in frequencies of intestinal parasitic infections (Table 3), according to the settings, HIV positive subjects were found significantly more infected in semi-urban/rural and rural settings (P < 0.0003), whereas the frequency of intestinal parasitic infections was significantly higher in HIV negative individuals in urban settings (P = 0.0418). Overall, frequencies of these parasitic infections were higher in rural and semi-urban/rural settings than in urban area (P = 0.0182).

Table 3. Rate of Intestinal Parasitic Infections Among Groups According to Socio-Demographic Parameters
Socio-Demographic ParametersHIV PositivesHIV NegativesTotal, No. (%)P Value
Examined, No.Infected, No. (%)Examined, No.Infected, No. (%)
Areas28379 (27.9)24555 (22.4)134 (25.4)0.1502
Urban20236 (17.8)9226 (28.3)62 (21.1)0.0418a
Intermediate3920 (51.3)12326 (21.1)46 (28.4)0.0003a
Rural4223 (54.8)3003 (10.0)26 (36.1)< 0.0001a
Male 8229 (35.4)9025 (27.8)54 (31.4)0.2835
Female 20150 (24.9)15530 (19.3)80 (22.5)0.2161
Age groups
[1, 15]0ND5307 (13.2)07 (13.2)ND
[15, 29]3005 (16.7)8008 (11.25)13 (11.8)0.2562
[29, 45]14045 (32.1)6534 (52.3)79 (38.5)0.0056a
> 4511329 (25.7)4703 (6.4)32 (20.0)0.0055a
Sectors of activity
S14504 (8.9)3920 (51.3)24 (28.6)< 0.0001a
S24723 (48.9)2206 (27.3)29 (42.0)0.0891
S317047 (27.6)9419 (20.2)66 (25.0)0.1821
S41405 (35.7)2201 (4.5)06 (16.7)0.0241a
S570 (0.0)6809 (13.2)09 (12.0)0.5880

Abbreviations: ND, not determined; S1, employees of administrations, public and private enterprises (formal sector); S2, agricultural workers or farmers (informal sector); S3, non-agricultural workers or small businessmen (informal sector); S4, unemployed; S5, other inactive (children, pupils, students).

aSignificant difference.

According to the genders the variations in frequencies of intestinal parasitic infections observed among HIV positive and HIV negative subjects were not significant, although males were in general significantly more infected than females (P = 0.0272).

According to age groups, HIV negative subjects aged 29 - 45 were more infected with intestinal parasites than their HIV positive counterparts (P = 0.0056). Moreover, HIV positive subjects aged 45 and over were more infected (P = 0.0055). Overall, frequencies of parasitic infections observed were significantly different between age groups (P < 0.0001), with the infection rate being higher in the age groups of 29 - 45.

Regarding sectors of activity, HIV negative individuals working in the formal sector were more infected with intestinal parasites than HIV positive individuals (P < 0.0001). In addition, unemployed HIV positive individuals were more infected compared to their HIV negative counterparts (P = 0.0241). Overall, frequencies of intestinal parasitic infections were significantly different across sectors of activity (P = 0.0008), the infection rate being higher among agricultural workers (informal sector).

Amongst HIV infected subjects, Cryptosporidium spp. was significantly associated with the decrease in CD4 cell count (P = 0.0035), individuals infected with this parasite species exhibiting a CD4 count < 500 cells/mm3 (Table 4). A significant difference was observed in the prevalence of Blastocystis spp. among HIV positive and HIV negative individuals (P = 0.0453). However, Blastocystis spp. was more frequent among individuals exhibiting CD4 count ≥ 500 cells/mm3. In addition, the prevalence of A. lumbricoides was significantly higher among HIV positive individuals in clinical stage A (25.0%) (P = 0.0013).

Table 4. Variation in the Rate of Intestinal Parasitic Infections in HIV Positive Subjects According to Some Variablesa
ParametersExamined Persons, NBlastocystis spp.E. histolytica/disparCryptospo-ridium spp.E. NanaI. buetschliiE. hartmanniI. belliG. intes-tinalisA. lumbricoïdes
CD4 cells numbers, cells/mm3
< 200320 (0.0)0 (0.0)3 (9.4)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
[200-500]1548 (5.2)12 (7.8)17 (11.0)7 (4.5)1 (0.6)0 (0.0)2 (1.3)1 (0.6)3 (1.9)
≥ 5009711 (11.3)10 (10.3)0 (0.0)3 (3.1)1 (1.0)2 (2.1)0 (0.0)0 (0.0)3 (3.1)
P value0.0453b0.16780.0035b0.65701.00000.20690.62561.00000.7134
HIV clinical stages
A120 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)3 (25.0)
B24319 (7.8)22 (9.1)15 (6.2)8 (3.3)2 (0.8)2 (0.8)2 (0.8)1 (0.4)3 (1.2)
C280 (0.0)0 (0.0)5 (17.9)2 (7.1)0 (0.0)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
P value0.32750.17340.09060.53411.00001.00001.00001.00000.0013b
Under ARV24019 (7.9)17 (7.1)13 (5.4)10 (4.2)0 (0.0)2 (0.8)0 (0.0)0 (0.0)6 (2.5)
Not under ARV430 (0.0)5 (11.6)7 (16.3)0 (0.0)2 (4.7)0 (0.0)2 (4.7)1 (2.3)0 (0.0)
P value0.08930.34920.0191b0.23570.0226b1.00000.0226b0.15190.5955

Abbreviations: A, B, C, clinical stages HIV according to the CDC classification (1993); ARV, antiretroviral; CD4, cluster differentiation 4.

aValues are expressed as No. (%).

bSignificant difference.

The infections with Cryptosporidium spp., I. belli, and I. buetschlii were significantly higher in HIV positive patients not taking antiretroviral (P < 0.0226). Although all HIV infected patients had already taken at least one treatment against intestinal pathogens, only 44.1% of the HIV seronegative individuals had taken a treatment against intestinal parasites a month prior to the outset of the study. For individuals who had taken antiparasitic treatment for intestinal infections within one month prior to the sampling, the frequency of Blastocystis spp. was significantly higher in HIV negatives (13.1%) than in HIV positives (6.7%) (P = 0.0333). P. hominis (2.3%) and E. coli (3.8%) were observed only among HIV seronegative individuals (P < 0.0306). In addition, 15 cases (2.8%) of co-infections by intestinal parasites were observed, with 5 cases (1.8%) among HIV positive and 10 (4.1%) amongst HIV negative individuals.

5. Discussion

The objective of this study was to assess the infection with intestinal parasites among HIV positive individuals attending four care units in the Center Region of Cameroon. The rates of intestinal parasitic infections were relatively high in both HIV positive and negative subjects attending the targeted care units. However, the rates of parasitic infections in HIV positive individuals have decreased over time as was previously observed elsewhere (4, 23, 24). This can be explained by the improvement in patients’ care though (i) systematic antibiotics, (ii) antiretroviral therapy, and (iii) nutritional and hygienic advices (25-27) provided at care units that have been created in all regions of the country.

The parasites frequently found in both groups were Blastocystis spp. and Entamoeba histolytica/dispar. Cryptosporidium spp. and E. histolytica/dispar were found at higher frequency amongst HIV positive patients. A similar trend was observed for Isospora belli, Entamoeba hartmanni, and Giardia intestinalis though at very low frequencies. Furthermore, Pentatrichomonas hominis and Entamoeba coli were only found amongst HIV seronegative subjects, though at low frequencies. The only helminth species was Ascaris lumbricoides. These different species are recurrent and usually identified in studies carried out in a tropical environment; their transmission is linked to the faecal peril (5, 7, 28-30).

In HIV positive patients, Cryptosporidium spp. was significantly associated with decreased CD4 cell count. Indeed, subjects infected with this parasite exhibited a CD4 count < 500 cells/mm3, confirming the opportunistic nature of this pathogen. Similar results have been previously described elsewhere, and it was accepted that Cryptosporidium spp. and I. belli are generally associated with immunosuppression (4, 7, 31, 32). Also, Cryptosporidium spp., I. belli, and I. buetschlii were found in a significantly high frequency in HIV infected patients who were not taking antiretroviral therapy. It was previously demonstrated that the antiretroviral treatment significantly reduces the viral load of HIV infected individuals, leading to the reconstitution of the immune system of the latter, whose defense cells can efficiently fight against these parasitic species (7).

HIV positive subjects were significantly more infected with intestinal parasites than HIV negative subjects in semi-urban, semi-rural, and rural settings, among individuals aged more than 45 years, as well as among the unemployed individuals. This would be explained by the differences in behavior between individuals from these settings, both in terms of awareness and hygiene, but also lack or insufficient resources for diagnostics and treatments, the relatively low financial resources, the impoverishment of these individuals, and decrease of their immunological status (1, 33, 34).

5.1. Conclusions

This study revealed that Cryptosporidium spp., Entamoeba histolytica/dispar, and Blastocystis spp. were the most prevalent intestinal parasites among HIV infected individuals, Cryptosporidium spp. exhibiting an opportunistic character. Furthermore, the socio-demographic factors associated with infection by these intestinal parasites among HIV infected individuals were the level of urbanization and the age of participants. These findings should therefore be taken into account while organizing the care of HIV infected individuals.




  • 1.

    World Health Organization. The partnership for parasite control. Notes of the second meeting, Rome, 25-26 April 2002. Geneva: WHO; 2002.

  • 2.

    UNAIDS. Report: The numbers of the epidemic.; 2012.

  • 3.

    CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19. [PubMed: 1361652].

  • 4.

    Same-Ekobo A, Lohoue J, Mbassi A. [A clinical and biological study of parasitic and fungal diarrhea in immunosuppressed patients in an urban and suburban area of Yaounde]. Sante. 1997;7(6):349-54. French. [PubMed: 9503491].

  • 5.

    Konate A, Minta D, Diarra M, Dolo A, Dembele M, Diarra B, et al. [Intestinal parasitosis during AIDS diarrhoea]. Bull Soc Pathol Exot. 2005;98(1):33-5. French. [PubMed: 15915971].

  • 6.

    Sadraei J, Rizvi MA, Baveja UK. Diarrhea, CD4+ cell counts and opportunistic protozoa in Indian HIV-infected patients. Parasitol Res. 2005;97(4):270-3. doi: 10.1007/s00436-005-1422-7. [PubMed: 16001279].

  • 7.

    French Association of Parasitology and Mycology Teachers: ANOFEL. [Parasitic and fungal infections of temperate and tropical regions; to succeed ECNi]. 5th ed. Elsevier Masson; 2016. 504 p. French.

  • 8.

    Meamar AR, Rezaian M, Mohraz M, Hadighi R, Kia EB. Strongyloides stercoralis hyper-infection syndrome in HIV+/AIDS patients in Iran. Parasitol Res. 2007;101(3):663-5. doi: 10.1007/s00436-007-0531-x. [PubMed: 17401580].

  • 9.

    Michiels JF, Saint Paul MC, Hofman P, Perrin C, Giorsetti V, Bernard E, et al. [Histopathologic features of opportunistic infections of the small intestine in acquired immunodeficiency syndrome]. Ann Pathol. 1992;12(3):165-73. French. [PubMed: 1326969].

  • 10.

    Shimelis T, Tassachew Y, Lambiyo T. Cryptosporidium and other intestinal parasitic infections among HIV patients in southern Ethiopia: Significance of improved HIV-related care. Parasit Vectors. 2016;9(1):270. doi: 10.1186/s13071-016-1554-x. [PubMed: 27165271]. [PubMed Central: PMC4862162].

  • 11.

    Adam AH, Nin Key EK, Lokrou A. HIV Association: Parasitic and fungal infections in Africa: Clinical and aetiopathogenic aspects. Médecine d'Afrique Noire. 1994;452:115-6.

  • 12.

    Adamu H, Petros B. Intestinal protozoan infections among HIV positive persons with and without antiretroviral treatment (ART) in selected ART centers in Adama, Afar and Dire-Dawa, Ethiopia. Eth J Health Dev. 2010;23(2):133-40. doi: 10.4314/ejhd.v23i2.53230.

  • 13.

    Adamu H, Wegayehu T, Petros B. High prevalence of diarrhoegenic intestinal parasite infections among non-ART HIV patients in Fitche Hospital, Ethiopia. PLoS One. 2013;8(8). e72634. doi: 10.1371/journal.pone.0072634. [PubMed: 23991132]. [PubMed Central: PMC3753330].

  • 14.

    Amoo JK, Akindele AA, Amoo AOJ, Efunshile AM, Ojurongbe TA, Fayemiwo SA, et al. Prevalence of enteric parasitic infections among people living with HIV in Abeokuta, Nigeria. Pan Afr Med J. 2018;30:66. doi: 10.11604/pamj.2018.30.66.13160. [PubMed: 30344850]. [PubMed Central: PMC6191249].

  • 15.

    National Program Against AIDS: PNLS. Five-year plan HIV/AIDS Cameroon. MINSANTE, Department of Community Health, Epidemiology Section; 1998.

  • 16.

    Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136(6):1952-65. doi: 10.1053/j.gastro.2008.12.073. [PubMed: 19457421].

  • 17.

    Saki J, Khademvatan S, Foroutan-Rad M, Gharibzadeh M. Prevalence of intestinal parasitic infections in haftkel county, southwest of Iran. Int J Infect. 2016;4(4). e15593. doi: 10.5812/iji.15593.

  • 18.

    National Institute of Statistics: INS and ICF International. Yaoundé, Cameroon. Caverton, Maryland, USA: INS and ICF International. Demographic, Health and Multiple Indicators Survey of Cameroon; 2011.

  • 19.

    National Atlas of Physical Development of Cameroon. 2013, [cited 16 May 2018]. Available from:économiques-du-cameroun.

  • 20.

    Rousset JJ. [Practical copro-parasitology. Interest and methodology. Notions on parasites of the digestive tract]. 1st ed. Paris ERSTEM; 1993. 106 p. French.

  • 21.

    Ripert C . [Epidemiology of parasitic diseases, Volume 3. Protozooses and helminthoses, reservoirs, vectors and transmission]. 1st ed. Cachan: Lavoisier; 2003. 419 p. French.

  • 22.

    Tuli L, Singh DK, Gulati AK, Sundar S, Mohapatra TM. A multiattribute utility evaluation of different methods for the detection of enteric protozoa causing diarrhea in AIDS patients. BMC Microbiol. 2010;10:11. doi: 10.1186/1471-2180-10-11. [PubMed: 20078872]. [PubMed Central: PMC2820438].

  • 23.

    Lehman LG, Kangam L, Mbenoun ML, Zemo Nguepi E, Essomba N, Tonga C, et al. Intestinal parasitic and candida infection associated with HIV infection in Cameroon. J Infect Dev Ctries. 2013;7(2):137-43. doi: 10.3855/jidc.2757. [PubMed: 23416660].

  • 24.

    Sarfati C, Bourgeois A, Menotti J, Liegeois F, Moyou-Somo R, Delaporte E, et al. Prevalence of intestinal parasites including microsporidia in human immunodeficiency virus-infected adults in Cameroon: A cross-sectional study. Am J Trop Med Hyg. 2006;74(1):162-4. [PubMed: 16407362].

  • 25.

    Alemu G, Alelign D, Abossie A. Prevalence of opportunistic intestinal parasites and associated factors among HIV patients while receiving ART at Arba Minch Hospital in Southern Ethiopia: A cross-sectional study. Ethiop J Health Sci. 2018;28(2):147-56. doi: 10.4314/ejhs.v28i2.6. [PubMed: 29983512]. [PubMed Central: PMC6016335].

  • 26.

    Ministry of Public Health. National guide for the care of people living with HIV/AIDS-Cameroon. 2005.

  • 27.

    Senn N, Fasel E, De Valliere S, Genton B. [Digestive disorders associated with protozoa and helminths: Taken care of by the family doctor]. Rev Med Suisse. 2010;6:2292-301. Frence.

  • 28.

    Ka R, Dia NM, Dia ML, Tine D, Diagne RD, Diop SA, et al. [Parasitic and bacterial etiologies of diarrhea among people living with HIV hospitalized in Fann hospital (Senegal)]. Mali Med. 2011;26(1):7-11. French. [PubMed: 22766136].

  • 29.

    Nkenfou CN, Tchameni SM, Nkenfou CN, Djataou P, Simo UF, Nkoum AB, et al. Intestinal parasitic infections in human immunodeficiency virus-infected and noninfected persons in a high human immunodeficiency virus prevalence region of Cameroon. Am J Trop Med Hyg. 2017;97(3):777-81. doi: 10.4269/ajtmh.16-0900. [PubMed: 28722574]. [PubMed Central: PMC5590583].

  • 30.

    Lanuza MD, Carbajal JA, Villar J, Mir A, Borras R. Soluble-protein and antigenic heterogeneity in axenic Blastocystis hominis isolates: pathogenic implications. Parasitol Res. 1999;85(2):93-7. [PubMed: 9934956].

  • 31.

    Tian LG, Wang TP, Lv S, Wang FF, Guo J, Yin XM, et al. HIV and intestinal parasite co-infections among a Chinese population: An immunological profile. Infect Dis Poverty. 2013;2(1):18. doi: 10.1186/2049-9957-2-18. [PubMed: 23971713]. [PubMed Central: PMC3766051].

  • 32.

    Pavie J, Menotti J, Porcher R, Donay JL, Gallien S, Sarfati C, et al. Prevalence of opportunistic intestinal parasitic infections among HIV-infected patients with low CD4 cells counts in France in the combination antiretroviral therapy era. Int J Infect Dis. 2012;16(9):e677-9. doi: 10.1016/j.ijid.2012.05.1022. [PubMed: 22771183].

  • 33.

    Hennequinn C . [Opportunistic infections imported into HIV-infected individuals]. Med Ther. 1996;1(94-102). French.

  • 34.

    Gedle D, Kumera G, Eshete T, Ketema K, Adugna H, Feyera F. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia. J Health Popul Nutr. 2017;36(1):15. doi: 10.1186/s41043-017-0092-2. [PubMed: 28506307]. [PubMed Central: PMC5433156].

  • Copyright © 2019, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.